BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezquer F, Bruna F, Calligaris S, Conget P, Ezquer M. Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease. World J Gastroenterol 2016; 22(1): 24-36 [PMID: 26755858 DOI: 10.3748/wjg.v22.i1.24] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
2 Lv Y, So KF, Xiao J. Liver regeneration and alcoholic liver disease. Ann Transl Med 2020;8:567. [PMID: 32775368 DOI: 10.21037/atm.2020.02.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
4 Ge L, Chen D, Chen W, Cai C, Tao Y, Ye S, Lin Z, Wang X, Li J, Xu L, Chen Y. Pre-activation of TLR3 enhances the therapeutic effect of BMMSCs through regulation the intestinal HIF-2α signaling pathway and balance of NKB cells in experimental alcoholic liver injury. Int Immunopharmacol 2019;70:477-85. [PMID: 30870678 DOI: 10.1016/j.intimp.2019.02.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
5 Thompson J, Jones N, Al-Khafaji A, Malik S, Reich D, Munoz S, MacNicholas R, Hassanein T, Teperman L, Stein L. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018;24:380-393. [PMID: 29171941 DOI: 10.1002/lt.24986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 14.0] [Reference Citation Analysis]
6 Damania A, Jaiman D, Teotia AK, Kumar A. Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury. Stem Cell Res Ther. 2018;9:31. [PMID: 29409540 DOI: 10.1186/s13287-017-0752-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 65] [Article Influence: 13.0] [Reference Citation Analysis]
7 Li YW, Zhang C, Sheng QJ, Bai H, Ding Y, Dou XG. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World J Gastroenterol 2017; 23(45): 7978-7988 [PMID: 29259373 DOI: 10.3748/wjg.v23.i45.7978] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
8 Vladimirovna IL, Sosunova E, Nikolaev A, Nenasheva T. Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation. J Immunol Res 2016;2016:7121580. [PMID: 27529074 DOI: 10.1155/2016/7121580] [Cited by in F6Publishing: 17] [Reference Citation Analysis]